Bayer’s proposed mega deal to buy Monsanto is likely to create a mega public relations challenge for the German company at home.
Bayer faces a backlash against Germany’s biggest planned acquisition because of two products from the St. Louis-based company that are widely detested in the country: genetically modified seeds and the weedkiller Roundup, which uses a compound called glyphosate that some believe can cause cancer.
Source: Bayer’s mega Monsanto deal faces mega backlash in Germany | Chicago Tribune